Article

Integration of inositol phosphate signaling pathways via human ITPK1

Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, USA.
Journal of Biological Chemistry (Impact Factor: 4.6). 10/2007; 282(38):28117-25. DOI: 10.1074/jbc.M703121200
Source: PubMed

ABSTRACT Inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1) is a reversible, poly-specific inositol phosphate kinase that has been implicated as a modifier gene in cystic fibrosis. Upon activation of phospholipase C at the plasma membrane, inositol 1,4,5-trisphosphate enters the cytosol and is inter-converted by an array of kinases and phosphatases into other inositol phosphates with diverse and critical cellular activities. In mammals it has been established that inositol 1,3,4-trisphosphate, produced from inositol 1,4,5-trisphosphate, lies in a branch of the metabolic pathway that is separate from inositol 3,4,5,6-tetrakisphosphate, which inhibits plasma membrane chloride channels. We have determined the molecular mechanism for communication between these two pathways, showing that phosphate is transferred between inositol phosphates via ITPK1-bound nucleotide. Intersubstrate phosphate transfer explains how competing substrates are able to stimulate each others' catalysis by ITPK1. We further show that these features occur in the human protein, but not in plant or protozoan homologues. The high resolution structure of human ITPK1 identifies novel secondary structural features able to impart substrate selectivity and enhance nucleotide binding, thereby promoting intersubstrate phosphate transfer. Our work describes a novel mode of substrate regulation and provides insight into the enzyme evolution of a signaling mechanism from a metabolic role.

Download full-text

Full-text

Available from: Amanda R Stiles, Jul 06, 2015
0 Followers
 · 
78 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND AND PURPOSE: Ca(2+) -dependent Cl(-) secretion (CaCC) in airways and other tissues is due to activation of the Cl(-) channel TMEM16A (anoctamin 1). Earlier studies suggested that Ca(2+) activated Cl(-) channels are regulated by membrane lipid inositol phosphates, and that 1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphosphate octakis(propionoxymethyl) ester (INO-4995) augments CaCC. Here we examined whether TMEM16A is the target for INO4995, and if the channel is regulated by inositol phosphates. EXPERIMENTAL APPROACH: The effects of INO-4995 on CaCC were examined in overexpressing HEK293, colonic and primary airway epithelial cells as well as Xenopus oocytes. We used patch clamping, double electrode voltage clamp and Ussing chamber techniques. KEY RESULTS: We found that INO-4995 directly activates a TMEM16A whole cell conductance of 6.1 ± 0.9 nS/pF in overexpressing cells. The tetrakisphosphates Ins(3,4,5,6)P(4) or Ins(1,3,4,5)P(4) and enzymes controlling levels of InsP(4) or PIP(2) and PIP(3) had no effects on the magnitude or kinetics of TMEM16A currents. In contrast in Xenopus oocytes, human airways and colonic cells, which all express TMEM16A endogenously, Cl(-) currents were not acutely activated by INO-4995. However incubation with INO-4995 augmented 1.6 -4 fold TMEM16A-dependent Cl(-) currents activated by ionomycin or ATP, while intracellular Ca(2+) signals were not affected. The potentiating effect of INO-4995 on transient ATP-activated TMEM16A-currents in CF airways was twice of that observed in non-CF airways. CONCLUSIONS AND IMPLICATIONS: These data indicate that TMEM16A is the target for INO-4995, although the mode of action appears different for overexpressed and endogenous channels. INO-4995 may be useful for the treatment of CF lung disease.
    British Journal of Pharmacology 09/2012; 168(1). DOI:10.1111/j.1476-5381.2012.02193.x · 4.99 Impact Factor
  • Source
    Advances in enzyme regulation 12/2009; 50(1):324-37. DOI:10.1016/j.advenzreg.2009.12.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Measurements of myo-inositolThe NTDs observed in the Itpk1 hypomorphs likely represent an example of folate-resistant NTDs. In humans, folic acid supplementation provides a 70% protective effect (Wald, 1991) leaving 30% which are folate-resistant. There are several animal models for folate-resistant NTDs. In some of these, the level of inositol affects the prevalence of the NTDs (Cockroft, 1988; Cockroft et al., 1992; Copp et al., 2003; Reece et al., 1997). In order to determine whether the NTDs seen in the Itpk1 hypomorphs result from a perturbation in inositol metabolism, animals will be fed diets containing varying levels of inositol and the prevalence of NTDs will be examined. To determine the level of inositol in the mouse chow as well as in the mice, to confirm that the levels of inositol are being altered, it is necessary to be able to assay for inositol concentrations. The enzyme inositol dehydrogenase (E.C.1.1.1.18) converts myo-inositol to scyllo-inosose in an NAD+-dependent oxidation reaction (Ramaley et al., 1979; Weissbach, 1965). Using purified solutions of inositol in a room temperature reaction containing 50 μg/ml of inositol dehydrogenase (Sigma Aldrich), the generation of NADH is measured by following the absorbance at 340 nm (Fig. 6A). Reactions reach their maximum absorbance by 70 minutes, as the A340 does not increase at time points beyond this time. To ensure that reactions go to completion, the A340 is read after 120 minutes. The assay is linear up to 0.25 mM inositol (Fig. 6B).Fig. 6Measurement of myo-inositol. (A). Time course for inositol dehydrogenase reaction. (B). Concentration-dependence of inositol dehydrogenase.For determination of inositol content in food (Harlan Teklad), samples were homogenized and extracted as described (Kawa et al., 2003). In addition to the standard mouse chow used by the Washington University Division of Comparative Medicine, two diet samples were obtained from Harlan Teklad (Madison, WI) for assay. Both test diets were based on the AIN-93 nutritionally complete rodent diet (Reeves et al., 1993). The level of inositol in the standard diet was 0.8 mg inositol/kg chow. A diet containing soybean oil (70 g/kg; TD.06706) and a diet containing 7% corn oil (TD.09146) both had reduced levels of inositol: 0.095 mg/kg and 0.072 mg/kg, respectively. We are currently assaying other test diets in order to obtain a relatively inositol free diet.
    Advances in enzyme regulation 11/2009; 50(1):365-72. DOI:10.1016/j.advenzreg.2009.10.017